Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 9;11(1):e0005224.
doi: 10.1371/journal.pntd.0005224. eCollection 2017 Jan.

Dengue in Latin America: Systematic Review of Molecular Epidemiological Trends

Affiliations

Dengue in Latin America: Systematic Review of Molecular Epidemiological Trends

José Ramos-Castañeda et al. PLoS Negl Trop Dis. .

Abstract

Dengue, the predominant arthropod-borne viral disease affecting humans, is caused by one of four distinct serotypes (DENV-1, -2, -3 or -4). A literature analysis and review was undertaken to describe the molecular epidemiological trends in dengue disease and the knowledge generated in specific molecular topics in Latin America, including the Caribbean islands, from 2000 to 2013 in the context of regional trends in order to identify gaps in molecular epidemiological knowledge and future research needs. Searches of literature published between 1 January 2000 and 30 November 2013 were conducted using specific search strategies for each electronic database that was reviewed. A total of 396 relevant citations were identified, 57 of which fulfilled the inclusion criteria. All four dengue virus serotypes were present and co-circulated in many countries over the review period (with the predominance of individual serotypes varying by country and year). The number of countries in which more than one serotype circulated steadily increased during the period under review. Molecular epidemiology data were found for Argentina, Bolivia, Brazil, the Caribbean region, Colombia, Ecuador, Mexico and Central America, Paraguay, Peru and Venezuela. Distinct lineages with different dynamics were found in each country, with co-existence, extinction and replacement of lineages occurring over the review period. Despite some gaps in the literature limiting the possibility for comparison, our review has described the molecular epidemiological trends of dengue infection. However, several gaps in molecular epidemiological information across Latin America and the Caribbean were identified that provide avenues for future research; in particular, sequence determination of the dengue virus genome is important for more precise phylogenetic classification and correlation with clinical outcome and disease severity.

PubMed Disclaimer

Conflict of interest statement

JRC is a member of the Sanofi Pasteur Scientific Advisory Board on Dengue Vaccine and received honorary from the company; ES is an employee of Sanofi Pasteur. GJ is a Director of Synercom Ltd, Macclesfield, UK, which received payment for medical writing services. FBdS, RMV, and JMGdA have no conflicts to declare.

Figures

Fig 1
Fig 1. The Latin American region.
The strict definition of ‘Latin America’ is the region of the Americas where Latin languages are spoken (Spanish, Portuguese and French). These countries have more in common with each other, sharing elements of historical experience, language and culture, than they do with North America. Nevertheless, Latin America is a diverse group of countries, with varied landscapes, peoples and cultures. However, for the purposes of this review, we included all countries within the Caribbean and Central and South America, and did not exclude countries located in the same region that speak other European languages, such as Belize, Guyana and the smaller Caribbean island nations. Colour code: Black: Brazil and Southern Cone; Dark Grey: Haiti and Latin Caribbean; Mid Grey: Mexico and Central America; Light Grey: Andean countries.
Fig 2
Fig 2. Result of literature search and evaluation of identified studies according to the preferred reporting items of systematic reviews and meta-analyses (PRISMA).
All references identified in the on-line database searches were assigned a unique identification number. Following the removal of duplicates and articles that did not satisfy the inclusion criteria from review of the titles and abstracts, the full papers of the first selection of references were retrieved either electronically or in paper form. A further selection was made based on review of the full text of the articles.
Fig 3
Fig 3. Distribution of DENV genotypes in the Americas region (2002–13).
The maps show the reported DENV genotypes by country between 2002 and 2013. The balloons indicate the country where the DENV was isolated, and the colour the genotypes determined. The maps were generated using ArcGIS 10.0 (http://www.strath.ac.uk/is/software/arcgis100-windows/) and modified proportionally to fit in the figure (the bar at the bottom of the panel represents 1,000 km).

References

    1. World Health Organization. Global Strategy for Dengue Prevention and Control: 2012–2020. Geneva: WHO; 2012. pp. 1–43.
    1. Selck FW, Adalja AA, Boddie CR. An estimate of the global health care and lost productivity costs of dengue. Vector Borne Zoonotic Dis 2014;14: 824–826. 10.1089/vbz.2013.1528 - DOI - PubMed
    1. Shepard DS, Coudeville L, Halasa YA, Zambrano B, Dayan GH. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 2011;84: 200–207. 10.4269/ajtmh.2011.10-0503 - DOI - PMC - PubMed
    1. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27: 1–13. - PubMed
    1. Guzman A, Isturiz RE. Update on the global spread of dengue. Int J Antimicrob Agents 2010;36 Suppl 1: S40–S42. - PubMed

Publication types